Actively Recruiting
HPC Offered for PRESERVE Expansion
Led by Ossium Health, Inc. · Updated on 2025-08-28
10
Participants Needed
4
Research Sites
265 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product
CONDITIONS
Official Title
HPC Offered for PRESERVE Expansion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 12 to 80 years
- Treated by a physician who determined eligibility for allogeneic bone marrow transplant
- Treated by a physician who determined that the potential benefit outweighs the potential risks
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
University of Alabama, Birmingham
Birmingham, Alabama, United States, 35294
Actively Recruiting
2
Henry Ford Health
Detroit, Michigan, United States, 48202
Actively Recruiting
3
The Ohio State University Medical Center
Columbus, Ohio, United States, 43210
Actively Recruiting
4
Tristar Centennial Medical Center
Nashville, Tennessee, United States, 37203
Actively Recruiting
Research Team
P
Preethi Prasad, Senior Director Clinical Operations
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here